Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Apothecary Capital
0
Apothecary Capital
Suggest edits
Overview
News
Investments
3
Portfolio
Portfolio Tracker
Add info
Xconomy
FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits
Health
Science
$62,000,000
Post-IPO equity
biospace
FibroGen Gets 62 Million License Payment from Partner AstraZeneca PLC
Health
Science
